Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.135 -0.205 (-2.19%)

Streaming Delayed Price Updated: 12:01 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

66 67 Next >

Here's The Good News For Novavax Ahead Of Its Fourth-Quarter Report ↗

February 28, 2023

Novavax is expected to report strong sales growth. But 2023 guidance will be key.

Via Investor's Business Daily

2 Stocks to Sell or Remove From Your Watchlist in 2023 ↗

February 28, 2023

Both stocks soared during the coronavirus vaccine race, but their time has passed.

Via The Motley Fool

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Nasdaq, S&P 500 Futures Flatline Ahead Of Housing, Consumer Data: Analyst Pins Hopes On Dollar, Fed Rates To Keep Flickering Rally Hopes Alive ↗

February 28, 2023

Trading in the U.S. index futures suggests stocks may start Tuesday’s session slightly higher, although the mood could be cautious ahead of some key economic data on the housing market, business...

Via Benzinga

Earnings Preview: Novavax ↗

February 27, 2023

Via Benzinga

Why Novavax Stock Wilted on Wednesday ↗

February 22, 2023

It doesn't seem like investors are looking forward to the company's fourth-quarter and full-year 2022 earnings release.

Via The Motley Fool

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

More Likely to 5x First: Novavax vs. Ocugen ↗

February 16, 2023

They skyrocketed before. It could happen again.

Via The Motley Fool

Here's the Worst Mistake Novavax Investors Can Make in 2023 ↗

January 20, 2023

Can Novavax still win over the long term?

Via The Motley Fool

3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying ↗

February 23, 2023

Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers.

Via The Motley Fool

2 Beaten-Down Stocks That Might Be too Cheap to Ignore ↗

February 22, 2023

There is an argument for hitting the buy button, but it's important to consider the potential risks too.

Via The Motley Fool

Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist ↗

February 21, 2023

The company offered neither financial guidance nor plans for a new CEO.

Via Investor's Business Daily

Is This the Telltale Sign to Sell Novavax Stock? ↗

February 14, 2023

You won't find Novavax's latest bad news trumpeted in a press release.

Via The Motley Fool

Why Is Monday.com (MNDY) Stock Up 11% Today? ↗

February 13, 2023

Monday.com (MNDY) stock is on the rise Monday after announcing a partnership with Appfire to expand its app marketplace.

Via InvestorPlace

NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S. ↗

February 13, 2023

Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.

Via InvestorPlace

These Cheap Growth Stocks Could Supercharge Your Portfolio ↗

February 12, 2023

All of these players are cheap today considering their growth potential.

Via The Motley Fool

Is Novavax Stock a Buy With the New Normal for COVID? ↗

February 10, 2023

The landscape has shifted dramatically in the COVID-19 vaccine market.

Via The Motley Fool

Better Buy: Novavax or BioNTech Stock? ↗

February 04, 2023

The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.

Via The Motley Fool

MarketBeat Week in Review – 1/30 - 2/3

February 04, 2023

The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot

Via MarketBeat

3 Sorry Pharma Stocks to Sell in February Before It’s Too Late ↗

February 01, 2023

These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility.

Via InvestorPlace

Novavax Shares Jumped in January While Others Slipped

February 01, 2023

Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.

Via MarketBeat

1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell ↗

February 01, 2023

Novavax shares sank 93% last year.

Via The Motley Fool

$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns ↗

January 30, 2023

The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.

Via Benzinga

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip ↗

January 27, 2023

The FDA's experts voted in favor of annual boosters on Thursday.

Via Investor's Business Daily

3 Great Growth Stocks Down 20% or More to Buy Now ↗

January 27, 2023

These beaten-down stocks could be poised for major rebounds.

Via The Motley Fool

This Investment Strategy Would Have Reduced Your Novavax Losses by 20% Last Year ↗

January 25, 2023

If you want to invest in volatile stocks, a certain strategy can minimize your overall risk.

Via The Motley Fool

3 Remarkable Stocks That Can Burn Short-Sellers Big-Time in 2023 ↗

January 24, 2023

Exceptionally high short interest in these innovative and transformative businesses may lead to a short squeeze.

Via The Motley Fool

Could Novavax Stock Help You Become a Millionaire? ↗

January 20, 2023

At such a beaten-down valuation, is the upside for Novavax just too significant to ignore?

Via The Motley Fool

River Private Wealth announces new round of investment in Novavax, Inc

January 19, 2023

Via AB Newswire

3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗

January 18, 2023

All three stocks have promising therapies that could drive revenue in the coming years.

Via The Motley Fool

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.